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Recent studies involving phytochemical polyphenolic compounds have suggested flavones often exert
pro-oxidative effect in vitro against wide array of cancer cell lines. The aim of this study was to evaluate
the in-vitro pro-oxidative activity of apigenin, a plant based flavone against colorectal cancer cell lines
and investigate cumulative effect on long term exposure. In the present study, treatment of colorectal cell
lines HT-29 and HCT-15 with apigenin resulted in anti-proliferative and apoptotic effects characterized
by biochemical and morphological changes, including loss of mitochondrial membrane potential which
aided in reversing the impaired apoptotic machinery leading to negative implications in cancer patho-
genesis. Apigenin induces rapid free radical species production and the level of oxidative damage was
assessed by qualitative and quantitative estimation of biochemical markers of oxidative stress. Increased
level of mitochondrial superoxide suggested dose dependent mitochondrial oxidative damage which was
generated by disruption in anti-apoptotic and pro-apoptotic protein balance. Continuous and persistent
oxidative stress induced by apigenin at growth suppressive doses over extended treatment time period
was observed to induce senescence which is a natural cellular mechanism to attenuate tumor formation.
Senescence phenotype inducted by apigenin was attributed to changes in key molecules involved in p16-
Rb and p53 independent p21 signaling pathways. Phosphorylation of retinoblastoma was inhibited and
significant up-regulation of p21 led to simultaneous suppression of cyclins D1 and E which indicated the
onset of senescence. Pro-oxidative stress induced premature senescence mediated by apigenin makes
this treatment regimen a potential chemopreventive strategy and an in vitro model for aging research.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Polyphenols are secondary metabolites of plants with dis-
tinctive biological effects [1]. Flavones represent the most studied
group of polyphenols with diverse bioactivity [2]. Widespread
phytochemical screening efforts have yielded numerous plant
based bioactive compounds with interesting therapeutic and
pharmaceutical virtue [3]. Recent advances in chemopreventive
strategies include optimization and development of diet derived
phytochemical therapeutic agents [4].
Apigenin (4′,5,7-trihydroxyflavone) is a plant flavone pre-
dominantly found in fruits and vegetables with interesting ther-
apeutic properties which includes chemopreventive, anti-muta-
genic and anti-carcinogenic activities [5]. These effects have often
been related to apoptosis induction, enhanced free radicalB.V. This is an open access article uproduction and increased oxidative stress [6,7]. Recent studies
involving phytochemical polyphenolic compounds have reported
that flavones exert a pro-oxidative effect in vitro and the phenoxyl
radicals generated result in mitochondrial membrane potential
collapse in a wide array of cancer cell lines [8,9]. The aim of the
present study was to evaluate the in-vitro pro-oxidative activity of
apigenin against colorectal cancer cell lines and also to investigate
the cumulative effect on long term exposure, to utilize it as a
potential chemotherapeutic drug.
The present study reports the biochemical changes involving
free radicals in vitro when colorectal cancer cells are treated with
bioactive flavone apigenin. Primary screening over a wide con-
centration range yielded loss of viability of the colorectal cell lines
chosen at higher doses. The IC50 (median inhibitory concentration)
in two different colorectal cell lines was determined (data unre-
ported) and concentration range of apigenin selected for the study
included concentrations above and below the respective IC50
molar concentrations of the individual cell lines. The present study
reports the ability of apigenin to elicit pro-oxidative damage in
both the colorectal cell lines. Dose–response studies yieldednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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shorter treatment regimens (high dose stress over time periods of
24 or 48 h) while senescence was elicited at low dosages over
longer treatment durations (low dose stress over a week treatment
regimen). Hence, apigenin mediated acute toxicity in vitro in col-
orectal cell lines leads to apoptosis while chronic toxicity leads to
senescence. The observations reported in this study suggested
apigenin treatment to be a potential chemo-preventive strategy
and potential cellular aging model.Materials and methods
Cell lines and cell culture conditions
Human colon carcinoma (CRC) cell lines HCT-15 (p53 mutant)
and HT-29 (p53 mutant) obtained from the National Centre for Cell
Science (NCCS), Pune, India were grown as adherent cultures in L-
glutamine supplemented RPMI-1640 medium with 10% heat-
inactivated FBS, 100 units/ml penicillin and 0.1 mg/ml streptomy-
cin at 37 °C in a 5% CO2 and 95% humidified incubator (Heraeus,
Hera Cell, Germany) [10]. After the cells reached 80% confluency,
they were trypsinized (0.25% Trypsin and 0.1% EDTA), centrifuged
(Heraeus Labofuge 400R, Germany), and suspended in RPMI-1640
medium. For subsequent experiments, the cells were seeded in
sterile 96-well plates, glass cover slips and 60 mm culture plates
respectively.
Chemicals and reagents
Apigenin, Senescence Cells Histochemical Staining Kit, Griess
reagent were purchased from Sigma Chemicals Co., USA. Dulbec-
co's modified Eagle's medium (DMEM) and Roswell Park Memorial
Institute 1640 medium (RPMI-1640) supplemented with L-gluta-
mine, fetal bovine serum (FBS), penicillin, streptomycin, Dulbec-
co's phosphate-buffered saline (D-PBS) and Hank's balanced salt
solution (HBSS) were all procured from Gibco (Invitrogen), USA.
JC-1 fluorescent dye was obtained from Life Technologies (Thermo
Fisher Scientific Corporation, Carlsbad, CA, USA). Phospho-Rb
(Ser780) Antibody, Bax Antibody, Bcl-2 Antibody, Anti-mouse IgG
and Anti-rabbit IgG were procured from Cell Signaling Technol-
ogys, USA while Anti-p21WAF1 (Ab-1) was obtained from Cal-
biochems, Darmstadt, Germany. Cyclin D1, Cyclin E, p53, p16
antibodies were procured from Santa Cruz Biotechnology, Inc.,
Dallas, USA while β-actin antibody was obtained from Sigma
Chemicals Co., USA. JC-1 fluorescent dye was obtained from Life
Technologies (Thermo Fisher Scientific Corporation, Carlsbad, CA,
USA). All other chemicals used were of the highest analytical grade
available. The chemicals were used as obtained without further
purification. Milli-Q water obtained from Milli-Q Integral 3 system
(Merck Millipore, Germany) was used for all experiments.
Qualitative and quantitative assessment of reactive oxygen species
(ROS)/reactive nitrogen species (RNS) generation
ROS/RNS generation was detected by using oxidant-sensitive
probe 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) as
described previously [11] with slight modifications. Briefly, both
HCT-15 and HT-29 cells were seeded at a density of 2104 cells on
sterile poly-L-lysine-coated glass cover slips or 60 mm petri dishes.
The adhered cells were treated with apigenin over a concentration
range of 1.5625–100 mM for 24 h respectively. ROS was qualita-
tively and quantitatively assessed using 5 mM of oxidant-sensitive
probe 2′,7′-dichlorofluorescein diacetate (H2DCFDA dissolved in
DMSO). Positive control consisted of tert-butyl hydroperoxide(100 mM) treated cells while negative control consisted of
untreated cells. Treated and untreated sets of the respective cell
lines were stained with H2DCFDA for 30 min at 37 °C. For quali-
tative assessment the cells seeded on glass cover slips were
observed under a Zeiss Observer. Z1 microscope with appropriate
filters (Ex/Em: 492–495/517–527 nm). The generated reactive
oxygen and nitrogen species converted the non-fluorescent
H2DCFDA to fluorescent 2′,7′-dichlorofluorescein (DCF) which and
was estimated with a fluro-spectrophotometer (Hitachi F-7000).
Quantitative assessment of reactive nitrogen species (RNS) generation
Both HCT-15 and HT-29 cells were seeded at a density of
2104 cells in sterile 96 well tissue culture plates. The adhered
cells were treated with apigenin over a concentration range of
1.5625–100 mM for 24 and 48 h respectively. The RNS generated
was quantitatively assessed using Griess reagent [1% (w/v) sulfa-
nilamide in 0.1 mol/l HCl and 0.1% N-(1-naphthyl)ethylenediamine
dihydrochloride] (Sigma Chemicals Co., USA) as described by the
manufacturer [12]. 100 ml Griess reagent was added to equivalent
amount of culture media and incubated at room temperature for
15 min in dark. The absorbance was then measured spectro-
photometrically at 540 nm using a benchmark microplate reader
(BioRad, USA).
Qualitative and quantitative analysis of mitochondrial transmem-
brane potential changes (ψm) based on epi-fluorescent microscopy
and cytometry
1106 HCT-15 and HT-29 cells were seeded in 60 mm tissue
culture plates and treated with apigenin at different concentrations for
24 h. Both adhered and floating cells were collected, washed three
times with PBS (1 ), incubated with 10 mg/ml of cyanine dye JC-1
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine
iodide) for 30 min at 37 °C. Mitochondrial membrane potential ana-
lysis was then performed with FACS Aria (BD Bioscience, USA) flow
cytometer with 10,000 events acquired for each sample and data
obtained was processed with BD FACS Diva software package bundled
with the instrument. For qualitative assessment cells were seeded on
cover slips, treated with different concentration of apigenin for 24 h,
washed thrice with PBS (1 ) and incubated with 10 mg/ml of JC-1 for
30 min at 37 °C. The cover slips were then observed under a Zeiss
Observer. Z1 microscope after 24 h.
Mitochondrial superoxide detection
Mitochondrial superoxide was detected using MitoSOX™ Red, a
novel fluorogenic dye highly selective for superoxide in the
mitochondria of live cells. Both HCT-15 and HT-29 cells were
seeded at a density of 2104 cells on sterile poly-L-lysine-coated
glass cover slips. The adhered cells were untreated or treated with
apigenin over a concentration range of 1.5625–100 mM for 24 h.
Treated and untreated sets of the respective cell lines were stained
with 5 mM MitoSOX™ for 10 min at 37 °C. The cells were washed
gently three times with PBS at room temperature and observed
under a Zeiss Observer. Z1 microscope with appropriate filter (Ex/
Em: 510/580 nm).
In situ cell death detection
The apoptotic cells were qualitatively visualized by using the
in situ cell death detection kit (Roche, USA) as described by the
manufacturer. Both HCT-15 and HT-29 cells were seeded at a
density of 5103 cells on sterile glass cover slips. The adhered
cells were untreated or treated with apigenin over a concentration
range of 1.5625–100 mM for 24 h. The cells were washed three
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paraformaldehyde (in PBS, pH 7.4) for 1 h at room temperature.
Cells were permeabilized with 0.1% Triton-X solution for 2 min.
Appropriate amounts of enzyme and labeling solutions were
mixed based on manufacturer’s instructions to make the TUNEL
reaction mixture. 50 ml of TUNEL reaction mixture was added each
sample and incubated at 37 °C for 60 min in dark. The samples
were washed thrice with PBS, mounted in fluorescent mounting
medium and viewed under Zeiss Observer. Z1 microscope.SA-β-Gal activity assay (senescence estimation)
The SA-β-gal activity assay was performed by using the
Senescence Cells Histochemical Staining Kit (Sigma Chemicals Co.,
USA) as described by the manufacturer. HCT-15 cells were seeded
at a density of 2104 cells on sterile 60 mm tissue culture plates.
The cells were treated at a concentration range from 1.5625 to
25 mM over an extended time period of 6 days as described pre-
viously [13]. The cells in sub-confluent cultures were washed
gently with PBS. The cells were subsequently fixed in 2% (v/v)
formaldehyde in PBS for 10 min at room temperature and then
incubated with a staining mixture containing 5-bromo-4-chloro-
3-indolyl β-D-galactoside, potassium ferricyanide, potassium fer-
rocyanide in citric acid–sodium phosphate buffer (pH 6.0). The
assay is based on a histochemical stain for β-galactosidase activity
(pH 6.0), resulted in the senescence positive cells being stained
blue/green.Cell signaling studies
1106 HCT-15 and HT-29 cells were seeded in 100 mm sterile
tissue culture plates and allowed to reach 75–90% confluence. Both
the cells were treated with apigenin at their respective apoptotic-
inducting and senescence-inducing dosage and were harvested at
indicated time point using NP-40 Cell Lysis Buffer supplemented
with 1 mM phenylmethylsulfonyl fluoride (Sigma Chemicals Co.,
USA) and protease and phosphatase inhibitors (Roche, USA). Pro-
teins were quantitated using the Bicinchoninic Acid (BCA) Protein
Assay kit (GeNei, Merck Millipore, Germany) in a benchtop plate
reader. Equivalent concentration of proteins were then carefully
loaded in each lane of a 12% polyacrylamide gel and electro-
phoresed appropriately. The proteins were meticulously trans-
ferred onto a nitrocellulose membrane (GE Healthcare Life Sci-
ences, United Kingdom), and the blots were probed with appro-
priate primary antibodies followed by secondary antibodies at
supplier's recommended dilutions. Immunoblots were then
developed using chemiluminescence (ECL) detection system
(Sigma Chemicals Co., USA).Statistical analysis
Graphpad Prism 5 software (GraphPad Software, Inc., La Jolla,
USA) was used for statistical analyses reported in this manuscript.
Data are presented as mean7S.D. (n¼3). The statistical sig-
nificance or variance was determined by using paired or unpaired
Student's t-test in experiments where control set values were
reported and one-way analysis of variance (ANOVA) in case of tests
where variance between experimental (test) sets were accessed.
*po0.05 was considered statistically significant while ***po0.001
was considered statistically highly significant.Results and discussion
Apigenin affects reactive oxygen species (ROS)/reactive nitrogen
species (RNS) generation
The increased green fluorescent intensity observed in the epi-
fluorescent images demonstrated the gradual surge in ROS/RNS
production with increasing dosage of apigenin in both HT-29 and
HCT-15 cell lines treated over 24 as compared with untreated cells
[Fig. 1g and h]. While the initial burst of ROS/RNS production in
treated sets of HCT-15 [Fig. 1a] was less than HT-29 [Fig. 1c] after
24 h, the trend was reversed after 48 h [Fig. 1b and d]. Treatment
with increasing concentrations of apigenin for 24 and 48 h resul-
ted in a significantly increased ROS generation in both cell lines
respectively, as compared with untreated cells [Fig. 1e and f]. Since
ROS has been previously reported as a possible mediator of
apoptosis, the observed resulted indicated the potential of api-
genin to induce apoptosis in treated cells [14].
Reactive nitrogen species (RNS) generation varies with time and dose
of apigenin treatment
The data reported in Section 3.1 suggested towards increased
reactive nitrogen species at both time points (24 and 48 h).
However, specific analysis of RNS generation using Griess reagent
revealed an interesting phenomenon. While the RNS levels were
significantly reduced in the treated groups of both cell lines with
respect to the control untreated set after 24 h, the trend was
completely reversed after 48 h. Furthermore the observed
decrease in the RNS levels after 24 h in treated sets were found to
be concentration dependent, with cells treated with higher doses
of apigenin producing reduced RNS generation In both cell lines
initially (24 h time point) RNS levels were significantly reduced in
the treated groups with respect to the control and the reduction
was concomitant with increasing drug treatment regime while
this trend was reversed as the treatment time progressed (48 h)
[Fig. 2]. these data were further substantiated when a one way
ANOVA in both HCT-15 and HT-29 cells for 24 and 48 h treatment
periods yielded a significant variance of po0.0001, representing
highly significant changes between the groups. The obtained
results indicating the initial reduction in RNS might have thus
contributed to the substantial difference between the reactive
oxygen/nitrogen species production values (obtained with
H2DCFDA) after 24 and 48 h reported in the previous section.
Apigenin induces mitochondrial transmembrane potential (ψm)
changes
Previous studies have reported changes in the mitochondria of
cells to reveal substantial information in the case of various
pathological conditions like cancer and aging since mitochondria
is the active site for reactive oxygen, nitrogen and superoxide
species generation [15]. The cationic dye JC-1 which at depolarized
membrane potentials exist as green-fluorescent monomer trans-
forms into orange-fluorescent JC-1 aggregates at hyperpolarized
membrane potentials has been utilized for discerning the changes
in mitochondrial membrane potential of HT-29 and HCT-15 cells
treated with apigenin. Flow cytometry results revealing higher
percentage of cells showing green fluorescence in both cell lines
when treated with increasing dose of apigenin suggested drug-
induced increased membrane depolarization [Fig. 3b and d] since
decreased red/green fluorescence intensity ratio is a measure of
mitochondrial depolarization.
Epi-fluorescence images exhibiting diffused green fluorescence
in cells treated with apigenin, unlike the punctate orange-red
fluorescent staining of the untreated control cells with healthy
Fig. 1. The effect of apigenin on the reactive oxygen species/reactive nitrogen species generation in HT-29, HCT-15 cells assessed using H2DCFDA over a treatment time
period of 24 and 48 h respectively. (a and b) Fluorescence emission spectra of HCT-15 treated and untreated sets at 24 and 48 h respectively. (c and d) Fluorescence emission
spectra of HT-29 treated and untreated sets at 24 and 48 h respectively. (e and f) Comparative assessment of the fluorescence maxima representing the quantitative
generation of reactive oxygen species/reactive nitrogen species in treated/untreated sets of both cell lines at 24 and 48 h. (g and h) Epi-Fluorescent images of HCT-15 and HT-
29 cells (A) untreated control (B–H) apigenin treated cells with dosage starting from 1.5625 mM and ranging to 100 mM. Comparative assessment of the fluorescence maxima
representing the quantitative generation of reactive oxygen species/reactive nitrogen species in treated/untreated sets of both cell lines at 24 and 48 h. Data represent the
means7S.D. of three independent experiments. Significant differences are indicated as ***po0.01, **po0.01 or *po0.05.
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Fig. 2. The effect of apigenin on the reactive nitrogen species generation in HT-29, HCT-15 cells over a time period of 24 and 48 h respectively. (a) and (c) Fold decrease in
reactive nitrogen species with respect to control in both cell lines at 24 h. (b) and (d) Fold increase in reactive nitrogen species with respect to control in both cell lines at
48 h.
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depolarized unhealthy mitochondria and corroborated with the
flow cytometry results [Fig. 3a and c].
Apigenin increases mitochondrial superoxide production
Recent advances in mitochondrial research have brought free
radical superoxide anion into the limelight as biologically sign-
ificant molecule [15]. Mitochondrial superoxide production related
cellular oxidative damage has been reported to be one of the
underlying causes of molecular alteration in many degradative
diseases and aging [16]. The fluorogenic dye MitoSOX™ Red tar-
gets mitochondria in live cells and is selectively oxidized by
mitochondrial superoxide present in live cells to produce red
fluorescence but remains unaltered by other ROS and/or RNS-
generating systems. The observed increase in red fluorescence
intensity in both HT-29 and HCT-15 cells with increasing dose of
apigenin indicated increased superoxide production [Fig. 4a and c].
In HT-29 cells, a significant increase (po0.05) in the fluorescence
intensity was observed at 1.5625 mM concentration of apigenin,
which further increased at successive higher dosages (po0.001).
However, in the case of HCT-15 cells, a significant increase in the
red fluorescence intensity was noticed at the drug concentration of
3.125 mM (po0.001) but was subsequently found to exhibit highly
significant changes above 12.5 mM concentration (po0.0001)
[Fig. 4b and d].
Acute toxicity mediated by apigenin induces apoptosis
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling (TUNEL) assay was performed to detect cells in the
late stages of apoptosis which have undergone extensive DNAdegradation [17]. Epi-fluorescent microscopy studies revealed
dose-dependent increased green fluorescent (TUNEL-positive)
apoptotic HT-29 and HCT-15 cells on treatment with apigenin with
respect to untreated control cells in the concentration range
examined [Fig. 5a and c]. The observed increase in the green
fluorescence intensities of the treated cells were analyzed by
ImageJ software (Fiji, USA) and were quantified as fold increase
with respect to the fluorescent intensity of untreated cells. While a
statistically significant increase in the fluorescence intensity was
observed from 1.56 mM concentration of apigenin treated HCT-15
cells, it was only observed from 3.125 mM drug dosage in the case
of HT-29 cells. Further analysis of the individual sets within the
respective test groups yielded highly significant change in the
fluorescence intensities amongst the various doses of apigenin
treated HCT-15 cells (po0.0001), unlike HT-29 cells (p 0.0129)
[one way ANOVA analysis]. The results thus, suggested greater
susceptibility of HCT-15 cells to apigenin in comparison to HT-29
cells [Fig. 5b and d].
Protein profiling of the cells exposed to cytotoxic stimuli eli-
cited by apigenin at higher dose at shorter treatment regimen
revealed disruption of the anti-apoptotic and pro-apoptotic pro-
tein balance. Simultaneous inhibition of anti-apoptotic protein Bcl-
2 and activation of pro-apoptotic effector Bax was observed
[Fig. 5e–g] which has been previously attributed to be the
underlying cause of the disruption of the mitochondrial outer
membrane [18].
Chronic toxicity mediated by apigenin induces aging
Cellular senescence is believed to represent a natural cellular
process to suppress tumor formation [19]. Senescent cells have
been reported to be characterized by expression of the senescence
Fig. 3. Change in mitochondrial transmembrane potential and early induction of apoptosis estimated by JC-1 in HT-29 and HCT-15 after 24 h treatment duration. (a) HT-29
treated and untreated sets, (c) HCT-15 treated and untreated sets, (b and d) flow cytometry graphs showing the percentage of cells with red or green fluorescence
respectively in treated or untreated sets of HCT-15 or HT-29 cells. Apigenin induces mitochondrial transmembrane potential changes in concentration-dependent manner
which is an indicator of early apoptosis.
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Fig. 4. Epi-fluorescent images representing changes in mitochondrial superoxide estimated by MitoSOX™ in HT-29 and HCT-15 after 24 h treatment duration. (a) HT-29
treated and untreated sets, (c) HCT-15 treated and untreated sets. (A) Micrograph of control/untreated group, (B–H) micrograph of treated group with dosage starting from
1.5625 mM and ranging to 50 mM. (b and d) Mean fluorescence intensity of treated and untreated sets in HT-29 and HCT-15 respectively. Data represent the means7S.D. of
three independent experiments. Significant differences are indicated as ***po0.01, **po0.01 or *po0.05.
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assay exhibited the occurrence of senescence in long term treat-
ment (6 days) with low doses of apigenin in HCT-15 cells [Fig. 6].Fig. 5. Epi-fluorescent images representing cellular death or apoptosis estimated by in
alterations in apoptotic and pro-apoptotic protein profile at high dosage treatment obser
(c) HT-29 treated and untreated sets. (A) Micrograph of control/untreated group, (B–H)
50 mM. (b and d) Mean fluorescence intensity of treated and untreated sets in HT-29 and
(e) Western blot analysis of Bcl-2, Bax in colorectal cancer cells untreated/treated with h
by western blot in apigenin treated/untreated HCT-15 and HT-29 cells respectively.Apigenin at concentrations above 25 mM failed to induce senes-
cence since it abrogated cellular viability and yielded very less
cells which could advance to growth and were thus not reportedsitu cell death detection kit after 24 h treatment duration and apigenin mediated
ved in colorectal cell lines HCT-15 and HT-29. (a) HCT-15 treated and untreated sets,
micrograph of treated group with dosage starting from 1.5625 mM and ranging to
HCT-15 respectively have been represented as fold increase with respect to control.
igh dose of apigenin. (f and g) Densitometric analysis of the protein bands obtained
Fig. 6. Phase contrast micrographs of (A) untreated/control HCT-15 cells, and (B–H) treated HCT-15 cells with apigenin (conc. range from 1.5625 to 25 mM) stained with
senescence Cells Histo-chemical staining kit after 5 day drug treatment regimen. Cells stained as blue/green represent senescent cells.
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apigenin to exhibit oxidative stress mediated premature senes-
cence which might represent a natural tumor suppressor
mechanism. This finding also corroborates with previous reports
of oxidative stress induced senescence in fibroblast cells [21].
Apigenin activates signaling pathways driving cellular senescence
Amongst the wide array of extrinsic stresses which activate the
cellular senescence program, ROS-dependent oxidative stress is an
integral component. In order to assess stress mediated changes in
the cellular signaling cascades, the expression and phosphoryla-
tion status of various cellular proteins was quantified. Since
chronic toxicity of apigenin was observed in earlier sections to
elicit cellular senescence in CRC cell lines, the induction of this
process was predicted to trigger key signaling pathways important
for cellular aging.
Protein profiling of apigenin-induced senescent CRC cells
revealed that both p16Ink4a-Rb and p53 independent p21 signaling
cascades were activated. Western blotting technique was utilized
to validate the involvement of the key downstream proteins of
both p16Ink4a-Rb and p53 independent p21 signaling pathwaysFig. 7. Apigenin mediated alterations in signaling pathways observed in colorectal cell li
p16, p53, p21WAF-1 proteins in colorectal cancer cells untreated/treated with senescenc
obtained by western blot in apigenin treated/untreated HCT-15 and HT-29 cells resp
alterations in colorectal cells occurring following apigenin treatment.[Fig. 7]. Retinoblastoma protein is a known tumor suppressor
protein which remains inactive in its phosphorylated state pRb.
While hyperphosphorylation of pRb results in the loss of its
capacity to restrict cell cycle progression from G1 to S phase,
hypophosphorylation of pRb induces growth-suppression [22].
Apigenin induced ROS generation primarily triggered sustained
and robust activation of p16Ink4a. In both HCT-15 and HT-29 which
carry mutant p53, apigenin treatment caused negligible change in
p53 however, simultaneous increase in p21 levels were observed
in both the cell lines. Thus, apigenin mediated increase in p21 was
executed through a p53 independent pathway. While the activa-
tion of p21 inhibited cyclin E expression, the activation of p16Ink4a
down-regulated cyclin D1. This ultimately caused temporal cell-
cycle arrest and inhibition of cell-cycle progression. Reminiscent to
previous reports the changes in the profiles of cyclins D1 and E
observed in our study hindered the Rb phosphorylation which
resulted in cell cycle arrest [23,24] corresponding to the onset of
senescence. The present study reported the specific role of cyclin
D1 in Rb phosphorylation at Ser780 which corroborated with
previous in vivo reports [25]. The p53 independent induction of
p21 elicited by apigenin is similar to earlier reports of effect ofnes HCT-15 and HT-29. (a) Western blot analysis of pRb (Ser780), cyclin E, cyclin D1,
e inductive dose of apigenin. (b and c) Densitometric analysis of the protein bands
ectively. (d) Schematic summary of p16INK4a-Rb and p53–p21 signaling pathway
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bearing p53 mutation [26].
The observed alterations in the key signaling molecules reg-
ulating the cell cycle suggested that apigenin triggered temporal
cell-cycle arrest and inhibited cell-cycle progression. This ulti-
mately induced senescence in the cells which represents a natural
cellular process to suppress tumor formation.Conclusions
The theory of “free radical theory of aging” first proposed by Dr.
Denham Harman in the 1950s [27] about the effects of reactive
species on aging has been demonstrated in this study, whereby the
treatment of colorectal cancer cells in vitro by apigenin mediated free
radical stress induced premature senescence. For shorter treatment
regime while higher concentrations of apigenin resulted in stress
which caused immediate apoptosis, lower concentrations of the drug
induced stress that led to marginal increase in ROS levels. Prominent
and continuous free radical production induced senescence pheno-
type at low drug concentrations for longer period. Thus, the present
study unearthed the cellular response either of senescence or
apoptosis of the colorectal cancer cells to apigenin to be a function of
the treatment duration rather than the severity of the stress.
The generation of pro-oxidants (like reactive oxygen species)
under normal physiological conditions is balanced by an equiva-
lent rate of its consumption by antioxidants enzymatically and/or
non-enzymatically [28]. It has already been reported that a dis-
ruption in the pro-oxidant-antioxidant equilibrium leads to “oxi-
dative stress” [28]. In the present study, apigenin was found to
induce increased ROS production at growth-suppressive con-
centrations in both HT-29 and HCT-15 colon cancer cell lines.
Further study of the other markers of oxidative stress revealed that
apigenin triggered increased pro-oxidative stress by eliciting
increased mitochondrial superoxide generation which resulted in
enhanced membrane depolarization in colon cancer cell lines.
Since increased mitochondrial membrane depolarization is known
to be an early marker of apoptosis, the obtained results pointed
towards the anti-tumorigenic potential of the flavones. The
molecular basis of the apoptotic potential of apigenin is ascribed to
the disruption in pro-apoptotic and anti-apoptotic protein balance
between Bcl-2 and Bax, which is the underlying cause of the
enhanced membrane depolarization in the colon cancer cell lines.
The study also reported that while exposure of cancer cells to
higher concentrations of apigenin over shorter time periods
induced acute toxicity which led to increased apoptosis, treatment
with lower concentrations of the drug for longer time points (6
days) resulted in chronic toxicity through increased reactive nitro-
gen species generation and senescence induction. Furthermore the
present study also revealed that although an increase in the total
reactive species production was observed, specific probing of the
RNS generation yielded decreased production at shorter time points
that was subsequently reversed with treatment time progression.
The nitric oxide free radical (NO) generated has already been
reported to be capable to form other reactive intermediates which
could trigger nitrosative damage on biomolecules, leading to age-
related diseases due to structural alteration of proteins or enzymatic
inhibition [29]. Thus, apigenin-induced nitrosative damage over
longer time periods may be the underlying basis of the subsequent
senescent phenotype which was characterized by the dysregulation
in key signaling proteins related to cell cycle progression that
included pRb, p16Ink4a and activated the p53 independent p21 sig-
naling cascade. Therapeutic molecules like apigenin which bypass
the p53 mediated pathway are increasingly generating interest in
the context of clinical application since loss of p53 function is
associated with most instances of colorectal cancer. The observedcellular senescence induced by extended low levels of oxidative
stress caused by apigenin could be utilized for chemoprevention as
well as an in vitro model for aging research in the future.Author contributions
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